Abstract

Background

Metastatic colorectal cancer (mCRC) most frequently occurs in elderly patients (pts), but these are less frequently treated with chemotherapy (CT) than younger ones. We report the final results of the first phase III study in elderly pts with mCRC receiving a 5FU-based CT with or without irinotecan.